SIMTRA BIOPHARMA SOLUTIONS

Lobbying client · Indiana · filed 2025 to 2026

Pharmaceuticals

$150,000 Reported spend

5 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page comes from one LDA client record (70212), filed by the registrant listed below.

Who filed for this client 1

SANDLER, TRAVIS & ROSENBERG, P.A. $150,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $100,000 3 filings
2025 $50,000 2 filings

Issues lobbied 1

Trade (domestic/foreign) 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 4
SENATE 4
Treasury, Dept of 2
U.S. Customs & Border Protection 2
U.S. International Trade Commission (ITC) 2
U.S. Trade Representative (USTR) 2

Recent filings 5 total

Q3 report

SANDLER, TRAVIS & ROSENBERG, P.A.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026

View → Q2 report

SANDLER, TRAVIS & ROSENBERG, P.A.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026

View → Q1 report

SANDLER, TRAVIS & ROSENBERG, P.A.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted Apr 20, 2026

View → Q4 report

SANDLER, TRAVIS & ROSENBERG, P.A.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026

View → Registration

SANDLER, TRAVIS & ROSENBERG, P.A.

4th Quarter 2025 (Oct 1 - Dec 31) · posted Dec 17, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.